IRIS
NECCHI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.189
NA - Nord America 1.133
AS - Asia 229
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
AF - Africa 6
OC - Oceania 3
Totale 2.576
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.126
SE - Svezia 896
SG - Singapore 121
IT - Italia 115
FI - Finlandia 61
DE - Germania 51
CN - Cina 47
IN - India 40
IE - Irlanda 30
EU - Europa 8
GB - Regno Unito 8
CA - Canada 6
ES - Italia 6
PL - Polonia 5
HK - Hong Kong 4
IR - Iran 4
JP - Giappone 4
NL - Olanda 4
PE - Perù 3
AU - Australia 2
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
FR - Francia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VN - Vietnam 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
KR - Corea 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 2.576
Salva come PNG Salva come JPEG
Città #
Lawrence 302
Princeton 302
Ashburn 146
New York 109
Helsinki 61
Shanghai 43
Milan 35
Dublin 30
Rome 29
Pune 20
Hanover 10
Washington 10
Los Angeles 7
Seattle 7
Singapore 7
Cologne 5
Borås 4
Burari 4
Chandigarh 4
Chyliczki 4
Vaprio d'Adda 4
Bilbao 3
Frankfurt am Main 3
Mumbai 3
Rozzano 3
The Bronx 3
Turin 3
Verona 3
Zanjan 3
Arvada 2
Azzano Decimo 2
Boardman 2
Bogotá 2
Delhi 2
Detroit 2
Genoa 2
Hanoi 2
Holyhead 2
Hyderabad 2
Jakarta 2
Latina 2
Lima 2
Lissone 2
Melbourne 2
Montevideo 2
Mushin 2
Nairobi 2
Nove Sady 2
Panorama City 2
Pescara 2
Pretoria 2
Redwood City 2
Rockville 2
Silver Spring 2
Alkmaar 1
Alton 1
Amritsar 1
Athens 1
Baku 1
Berlin 1
Brussels 1
Calgary 1
Castagneto 1
Central District 1
Chennai 1
Colne 1
Cortenuova 1
Desio 1
Dundee 1
Forio 1
Fort Lauderdale 1
Gainesville 1
Gunzenhausen 1
Hamamatsu 1
Hong Kong 1
Houston 1
Ichibancho 1
Jeddah 1
Kansas City 1
Karlsruhe 1
Kaunas 1
Larissa 1
Legnano 1
Leuven 1
Loudi 1
Majadahonda 1
Manchester 1
Mexico City 1
Middlesbrough 1
MitspeNetofa 1
Morgantown 1
Mountain View 1
Mykolayiv 1
Newcastle upon Tyne 1
Omaha 1
Osasco 1
Ottawa 1
Palmerston North 1
Pamplona 1
Pavia 1
Totale 1.263
Salva come PNG Salva come JPEG
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 28
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 26
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 26
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 24
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 24
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 24
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor beta (TGF beta) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial 24
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 23
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 22
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 22
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 22
A Plea for Economically Sustainable Evidence-based Guidelines 21
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 20
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 20
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 19
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 19
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 19
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 19
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 18
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 18
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 18
A risk calculator predicting recurrence in lymph node metastatic penile cancer 18
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 18
Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30 18
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 17
A global approach to improving penile cancer care 17
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 17
Primary Renal Tumour Response to Immunotherapy: Lessons from Metastatic Disease and Insights into Earlier Settings 17
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 16
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 16
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 16
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 16
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 16
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 15
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 15
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 15
Penile cancer 15
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 14
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 14
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 14
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 14
Targetable gene fusions and aberrations in genitourinary oncology 14
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 14
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review 14
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 13
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action 13
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma 13
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial 13
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 13
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 13
Should Upper-tract Urothelial Carcinoma and Bladder Carcinoma Be Treated the Same or Different? 13
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer 13
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial 13
Coming of Age of Immunotherapy of Urothelial Cancer 13
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition 13
Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer 12
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 12
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 12
Funcion sparing surgery in uro-oncology: germ cell tumors of the testis [La chirurgia "function sparing" in urologia oncologica: tumori germinali del testicolo (TGT)] 12
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 12
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy 12
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 12
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 12
Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities 12
The obesity paradox in metastatic castration-resistant prostate cancer 12
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis 12
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 12
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 12
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 11
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment Delivery 11
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 11
Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database 11
From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis 11
Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study 11
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial 11
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors 11
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 11
Evaluation of cognitive function in trials testing new-generation hormonal therapy in patients with prostate cancer: A systematic review 11
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 11
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 11
Re: Roisin M. Connolly, John A. McCaffrey. High-Dose Chemotherapy plus Stem Cell Transplantation in Advanced Germ Cell Cancer: A Review. Eur Urol 2009;56:57-64 10
EARLY AND LATE HEAT-SHOCK PROTEINS IN WHEATS AND OTHER CEREAL SPECIES 10
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 10
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 10
Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy for Urothelial Carcinoma sdfhzdfh 10
Postchemotherapy Lymphadenectomy in Patients With Metastatic Urothelial Carcinoma: Long-Term Efficacy and Implications for Trial Design 10
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 10
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 10
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 10
Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636–43 10
Understanding genomics and the immune environment of penile cancer to improve therapy 10
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer 10
Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55–65 10
Causal contributors to tissue stiffness and clinical relevance in urology 10
The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy 9
Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature 9
Neoplasie dell'Apparato genitale maschile: Testicolo 9
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors? 9
A Prognostic Model Including Pre- and Postsurgical Variables to Enhance Risk Stratification of Primary Mediastinal Nonseminomatous Germ Cell Tumors: The 27-Year Experience of a Referral Center 9
Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage i nonseminomatous germ cell tumours: Long-term outcome and analysis of risk factors of recurrence 9
Totale 1.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 5 0 0 2 2 0 0 0 2 2 0 0
2020/2021233 0 0 0 2 169 19 39 0 4 0 0 0
2021/2022270 0 53 3 101 1 8 13 10 13 11 4 53
2022/20231.668 675 354 123 38 18 233 47 94 48 5 15 18
2023/2024743 23 57 65 63 79 182 132 118 7 17 0 0
Totale 2.934